Skip to main navigation Skip to search Skip to main content

Minocycline does not affect amyloid beta phagocytosis by human microglial cells

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Activated microglia accumulate in amyloid beta (Abeta) plaques containing amyloid associated factors SAP and C1q in Alzheimer's disease (AD) brain. Microglia are involved in AD pathogenesis by promoting Abeta plaque formation and production of pro-inflammatory cytokines. On the other hand, phagocytosis of Abeta by activated microglia may prevent Abeta-mediated neurotoxicity and Abeta plaque formation. Minocycline, a tetracycline derivative, is neuroprotective in various neurodegenerative models as well as human chronic neurological disorders. Minocycline attenuates the release of TNF-alpha by human microglia upon exposure to a mixture of Abeta, SAP and C1q. Here, we demonstrate that minocycline down-regulates the production of pro-inflammatory cytokines by human microglia without affecting their beneficial activity, phagocytosis of amyloid beta fibrils
Original languageEnglish
Pages (from-to)87-91
JournalNeuroscience letters
Volume416
Issue number1
DOIs
Publication statusPublished - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Minocycline does not affect amyloid beta phagocytosis by human microglial cells'. Together they form a unique fingerprint.

Cite this